in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Ranbaxy Buys Biopharma Stake
1:20 PM MDT | October 22, 2007 | Chemical Week Editorial Staff
India’s largest pharmaceutical company Ranbaxy Laboratories (Gurgaon), says it has signed a definitive agreement to increase its stake in Zenotech Laboratories (Hyderabad, India) from 7%, to 45%. Zenotech develops and manufactures generic biopharmaceuticals and is a specialty generics injectable company. It also develops new biological entities in the areas of oncology and neurology. “The increasing importance of biologics in the global pharmaceutical industry and the opening up of generic biologics in the regulated markets makes it opportune for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee